Learn how we’re changing the world of medicine. Discover career opportunities, our product pipeline, and browse media resources. Meet Moderna.

Moderna initiates first-in-human dosing for mRNA-1653, a combination vaccine with the potential to protect against more than one disease–human metapneumovirus (hMPV virus) and …

Track the development of Moderna’s mRNA medicines. From preclinical development to commercial phase.

Nov 6, 2025 · Innovation Incubator New venture labs Terms of Use Site Map Privacy Policy Contact Moderna © 2025 Moderna, Inc.

Our Values Moderna people hold a deep sense of responsibility for each other, patients, the environment and our local communities. Our people live our Values every day.

In addition to mRNA vaccines, Moderna is working on other applications of potential mRNA therapeutics that could help people with cancer, metabolic diseases and more.

Join Moderna as we pursue the uncharted reaches of possibility and make your mark on the future of medicine.

Resources for journalists and media members. The latest press releases by Moderna.

Explore mRNAs as Medicines, a three-module course designed by experts at Moderna that offers a comprehensive understanding of mRNA medicines, how they work and their potential …

You should not get mNEXSPIKE if you had a severe allergic reaction after a previous dose of either mNEXSPIKE, SPIKEVAX (COVID-19 Vaccine, mRNA), or any Moderna COVID-19 …